Market Place
Sourcing Support
Miravo Healthcare™ and Searchlight Pharma Inc. Announce Closing of Arrangement
14 Mar 2023 //
BUSINESSWIRE
Miravo Healthcare™ Obtains Final Order Approving Plan of Arrangement
10 Mar 2023 //
BUSINESSWIRE
Miravo Healthcare™ Announces Shareholder Approval of Plan of Arrangement
07 Mar 2023 //
BUSINESSWIRE
Miravo Healthcare™ Special Meeting Reminder
21 Feb 2023 //
BUSINESSWIRE
Miravo Announces Filing of Materials in respect of Arrangement with Searchlight
07 Feb 2023 //
BUSINESSWIRE
Searchlight Pharma to acquire Miravo Healthcare
26 Dec 2022 //
INDIANPHARMAPOST
Miravo Healthcare™ Announces Third Quarter 2022 Results
14 Nov 2022 //
BUSINESSWIRE
Miravo Healthcare Announces Third Quarter 2022 Results Release Date
31 Oct 2022 //
BUSINESSWIRE
Miravo Healthcare Announces Appointment of Anthony Snow in Board of Directors
16 Aug 2022 //
BUSINESSWIRE
Miravo Healthcare Announces Q2 2022 Results Release Date and Conference Call
02 Aug 2022 //
BUSINESSWIRE
Miravo Appoints Dale MacCandlish Weil to its Board of Directors
24 May 2022 //
BUSINESSWIRE
Miravo Healthcare™ Announces First Quarter 2022 Results
16 May 2022 //
BUSINESSWIRE
Miravo Healthcare Announces Director Election Results
16 May 2022 //
BUSINESSWIRE
Miravo Healthcare Announces First Quarter 2022 Results Release Date
02 May 2022 //
BUSINESSWIRE
Miravo Healthcare Announces 2021 and Fourth Quarter Results
28 Mar 2022 //
BUSINESSWIRE
Miravo Healthcare Announces Q4 2021 Results Release and Conference Call Date
14 Mar 2022 //
BUSINESSWIRE
Miravo Healthcare Announces the Canadian Commercial Launch of Blexten
01 Mar 2022 //
BUSINESSWIRE
Miravo Health Announces Summary Judgment Ruling by US District Court
28 Feb 2022 //
BUSINESSWIRE
Miravo Healthcare to Participate at H.C. Wainwright Bioconnect Conference
06 Jan 2022 //
BUSINESSWIRE
Miravo Healthcare Announces Third Quarter 2021 Results
15 Nov 2021 //
BUSINESSWIRE
Miravo Healthcare™ Announces 2020 and Fourth Quarter Results
08 Mar 2021 //
PRNEWSWIRE
Copyright © 2024 LePro PharmaCompass OPC Private Limited, All rights reserved.